Meeting a Palpable Need in Breast Cancer
This article was originally published in Start Up
Executive Summary
Breast cancer, which has become one of the most significant health risks in the US, according to "US Markets for Breast Disease Detection and Diagnostic Technologies," a report published in March 2006 by the Medtech Insight division of Windhover Information. In 2005, breast cancer resulted in approximately 40,000 deaths, putting it right behind lung cancer as a leading cause of death. Companies with technologies for the early detection of the disease are operating in robust markets with high growth rates, according to the report, because breast cancer affects such a large number of women. One in seven women will develop the breast cancer in her lifetime. There is clearly a palpable need for improved detection and diagnostic technologies.
You may also be interested in...
In Brief January 2007
A brief summary of recent product developments in the device industry, including updates on Edwards Lifesciences, Cardiophonics, Boston Scientific. Also, short takes on the Pediatric Medical Device Safety and Improvement Act, and Annual Breast Cancer Screening.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.